Pharmacogenetics and Clinical Biomarkers for Subtherapeutic Plasma Efavirenz Concentration in HIV-1 Infected Thai Adults-Reference-Cited by-同舟云学术

Pharmacogenetics and Clinical Biomarkers for Subtherapeutic Plasma Efavirenz Concentration in HIV-1 Infected Thai Adults

Published:2014 Issue:4 Volume:29 Page:289-295
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Sukasem Chonlaphat,Chamnanphon Montri,Koomdee Napatrupron,Santon Siwalee,Jantararoungtong Thawinee,Prommas Santirat,Puangpetch Apichaya,Manosuthi Weerawat

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference37 articles.

1. Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation;Ogburn;Drug Metab. Dispos.,2010

2. The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity;Ward;J. Pharmacol. Exp. Ther.,2003

3. Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults;Sukasem;Br. J. Clin. Pharmacol.,2012

4. Plasma efavirenz concentrations and the association with CYP2B6-516G> T polymorphism in HIV-infected Thai children;Puthanakit;Antivir. Ther.,2009

5. Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection;Csajka;Clin. Pharmacol. Ther.,2003

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of rifampicin, CYP2B6 and ABCB1 polymorphisms on efavirenz plasma concentration in Chinese patients living with HIV and tuberculosis;International Journal of STD & AIDS;2022-11-10

2. HIV-positive women have higher prevalence of comorbidities and anticholinergic burden: assessment of the HIV-positive population from Menorca (Balearic Islands);AIDS Care;2022-04-27

3. Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies;Frontiers in Pharmacology;2022-02-18

4. Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings;Drug Metabolism and Pharmacokinetics;2021-08

5. Influence of SULT1A1*2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients;Pharmacogenomics and Personalized Medicine;2021-07